Men in Malawi face a higher risk of TB from adolescence - linked to exposure, smoking & alcohol use.
Bringing testing closer through mobile units is helping reach more men & detect more cases.
Ending TB among men protects everyone.
Watch @MphaDSP: youtu.be/wMP4f05lgHM?si=qh4S…#TB
Join us for an important conversation on advancing gender-responsive approaches to tuberculosis care.
🗓️ 31 March 2026 | ⏰12:00–13:30 BST
Explore 6 years of global health research, key findings & real-world impact.
➡️Register: shorturl.at/Ik96t#EndTB#GenderEquity
ALT Webinar: Advancing gender-responsive tuberculosis prevention and care: results, impact and legacy of the LIGHT research programme. 31 March 2026, 12:00-13:30 BST.
🚨 HAPPENING NOW | Lilongwe
@Afidep & @MLW_Programme & Malawi’s NTLEP host a high-level forum on gendered TB evidence—highlighting the disproportionate burden on men.
🎯 Turning evidence into action for more inclusive TB services
🔗 light.lstmed.ac.uk#LIGHTImpact
We are honored to be hosting the Wellcome Board of Governors and partners from LSTM, UoL and KUHeS here to learn more about our work tackling Malawi’s health challenges through science. Grateful for the positive feedback & looking forward to deepening our partnerships.
We are delighted to announce that Dr Debora Nyirenda
prestigious @wellcometrust Career Development Award. Her fellowship will advance innovative social science research focused on understanding how communities experience and respond to the health impacts of climate change.
New funding for infectious disease clinical trials! 📣
We’re funding randomised controlled trials to optimise existing vaccines and therapeutics for infectious diseases.
This research must be led by those closest to the challenge. The lead applicant must be based in a low- or middle-income country in Africa, South Asia, or South-East Asia.
Trials should focus on one of the following disease areas:
• mycobacterial infections (tuberculosis, leprosy or infections with non-tuberculous mycobacteria)
• bacterial infections (sexually transmitted infections, lower respiratory tract infections or bloodstream infections)
• invasive fungal infections
• dengue, leishmaniasis or schistosomiasis
If you have an innovative idea for a randomised controlled trial proposal, but need to build your team, develop your clinical trial protocol or generate pilot data, you can apply to our Infectious Disease Clinical Trial Development Award.
Delivered in partnership with @NIHRresearch and @FCDOResearch
Learn more about eligibility and how to apply ⤵️
wellcome.org/research-fundin…
Milestone in the fight against drug-resistant malaria in Southern Africa.
SADC health ministers endorsed a malaria report with a dedicated #DrugResistance section and agreed on next steps, including developing a regional strategy.
Read more: mlw.mw/news_and_events/sadc-…
TIBA Partnership welcomes @MLW_Programme as the latest TIBA Partner!
TIBA Director Prof. Woolhouse: "We greatly value TIBA Malawi's expertise in clinical research and training and look forward to a productive collaboration."
@JanelisaMusaya@kjambo@KEMRI_Wellcome@EdinburghUni
𝐀𝐍𝐍𝐎𝐔𝐍𝐂𝐄𝐌𝐄𝐍𝐓
The Malawi-Liverpool-Wellcome Research Programme (MLW) announces that Wellcome has approved a new seven-year core grant to underpin MLW’s scientific strategy, training programme, and research initiatives from 2025 – 2032.
mlw.mw/news_and_events/malaw…
Today, Thursday 15th May 2025, our Infection Prevention and Control (IPC) Implementation Team is conducting a training session for support staff (cleaners, hospital attendants and security personnel) at Zomba Central Hospital.
This initiative aims to equip these essential staff members with the necessary skills for proper surface cleaning and hygiene practices to help prevent the spread of infections within the hospital environment.
The training follows a similar program recently conducted for healthcare workers, including nurses and doctors, focusing on hand hygiene and infection control procedures relevant to their roles.